MRI performed after treatment of locally advanced rectal cancer can offer value in predicting patient outcomes, according to research published September 3 in Radiology. “Restaging MRI can stratify patients treated with total neoadjuvant therapy into clinical response categories predictive of organ preservation, local regrowth, and survival,” wrote a multi-institutional research team led by first author Hannah Williams, MD, and senior author Julio Garcia-Aguilar, MD, PhD, of Memorial Sloan Kettering Cancer Center in New York City.